Anne Kallioniemi

Anne Kallioniemi

UNVERIFIED PROFILE

Are you Anne Kallioniemi?   Register this Author

Register author
Anne Kallioniemi

Anne Kallioniemi

Publications by authors named "Anne Kallioniemi"

Are you Anne Kallioniemi?   Register this Author

80Publications

1712Reads

9Profile Views

Correction to: Depletion of nuclear import protein karyopherin alpha 7 (KPNA7) induces mitotic defects and deformation of nuclei in cancer cells.

BMC Cancer 2019 01 14;19(1):57. Epub 2019 Jan 14.

BioMediTech Institute and Faculty of Medicine and Life Sciences, University of Tampere, 100, 33014, Tampere, PL, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12885-018-5234-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6330744PMC
January 2019

Clinicopathological and prognostic correlations of HER3 expression and its degradation regulators, NEDD4-1 and NRDP1, in primary breast cancer.

BMC Cancer 2018 Oct 26;18(1):1045. Epub 2018 Oct 26.

BioMediTech Institute and Faculty of Medicine and Life Sciences, University of Tampere, Tampere, Arvo Ylpön katu 34, 33520, Tampere, Finland.

View Article

Download full-text PDF

Source
https://bmccancer.biomedcentral.com/articles/10.1186/s12885-
Publisher Site
http://dx.doi.org/10.1186/s12885-018-4917-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6204010PMC
October 2018

Wound healing of human embryonic stem cell-derived retinal pigment epithelial cells is affected by maturation stage.

Biomed Eng Online 2018 Jul 31;17(1):102. Epub 2018 Jul 31.

Faculty of Medical and Life Sciences, BioMediTech, University of Tampere, Arvo Ylpön Katu 34, Tampere, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12938-018-0535-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6069779PMC
July 2018

Depletion of nuclear import protein karyopherin alpha 7 (KPNA7) induces mitotic defects and deformation of nuclei in cancer cells.

BMC Cancer 2018 03 27;18(1):325. Epub 2018 Mar 27.

BioMediTech Institute and Faculty of Medicine and Life Sciences, University of Tampere, PL 100, 33014, Tampere, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12885-018-4261-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5870926PMC
March 2018

Transcription factors-Intricate players of the bone morphogenetic protein signaling pathway.

Genes Chromosomes Cancer 2018 01 27;57(1):3-11. Epub 2017 Sep 27.

BioMediTech Institute and Faculty of Medicine and Life Sciences, University of Tampere, Tampere, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/gcc.22502DOI Listing
January 2018

Paclitaxel, Carboplatin and 1,25-D3 Inhibit Proliferation of Endometrial Cancer Cells .

Anticancer Res 2017 12;37(12):6575-6581

Department of Obstetrics and Gynaecology, Tampere University Hospital, Tampere, Finland.

View Article

Download full-text PDF

Source
http://ar.iiarjournals.org/content/37/12/6575.abstract
Publisher Site
http://dx.doi.org/10.21873/anticanres.12114DOI Listing
December 2017

RAD51B in Familial Breast Cancer.

Authors:
Liisa M Pelttari Sofia Khan Mikko Vuorela Johanna I Kiiski Sara Vilske Viivi Nevanlinna Salla Ranta Johanna Schleutker Robert Winqvist Anne Kallioniemi Thilo Dörk Natalia V Bogdanova Jonine Figueroa Paul D P Pharoah Marjanka K Schmidt Alison M Dunning Montserrat García-Closas Manjeet K Bolla Joe Dennis Kyriaki Michailidou Qin Wang John L Hopper Melissa C Southey Efraim H Rosenberg Peter A Fasching Matthias W Beckmann Julian Peto Isabel Dos-Santos-Silva Elinor J Sawyer Ian Tomlinson Barbara Burwinkel Harald Surowy Pascal Guénel Thérèse Truong Stig E Bojesen Børge G Nordestgaard Javier Benitez Anna González-Neira Susan L Neuhausen Hoda Anton-Culver Hermann Brenner Volker Arndt Alfons Meindl Rita K Schmutzler Hiltrud Brauch Thomas Brüning Annika Lindblom Sara Margolin Arto Mannermaa Jaana M Hartikainen Georgia Chenevix-Trench Laurien Van Dyck Hilde Janssen Jenny Chang-Claude Anja Rudolph Paolo Radice Paolo Peterlongo Emily Hallberg Janet E Olson Graham G Giles Roger L Milne Christopher A Haiman Fredrick Schumacher Jacques Simard Martine Dumont Vessela Kristensen Anne-Lise Borresen-Dale Wei Zheng Alicia Beeghly-Fadiel Mervi Grip Irene L Andrulis Gord Glendon Peter Devilee Caroline Seynaeve Maartje J Hooning Margriet Collée Angela Cox Simon S Cross Mitul Shah Robert N Luben Ute Hamann Diana Torres Anna Jakubowska Jan Lubinski Fergus J Couch Drakoulis Yannoukakos Nick Orr Anthony Swerdlow Hatef Darabi Jingmei Li Kamila Czene Per Hall Douglas F Easton Johanna Mattson Carl Blomqvist Kristiina Aittomäki Heli Nevanlinna

PLoS One 2016 5;11(5):e0153788. Epub 2016 May 5.

Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0153788PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4858276PMC
July 2017

Germline EMSY sequence alterations in hereditary breast cancer and ovarian cancer families.

BMC Cancer 2017 Jul 24;17(1):496. Epub 2017 Jul 24.

Institute of Biosciences and Medical Technology - BioMediTech, University of Tampere, Lääkärinkatu 1, FI-33520, Tampere, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12885-017-3488-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5525221PMC
July 2017

Search for KPNA7 cargo proteins in human cells reveals MVP and ZNF414 as novel regulators of cancer cell growth.

Biochim Biophys Acta Mol Basis Dis 2017 01 21;1863(1):211-219. Epub 2016 Sep 21.

University of Tampere, BioMediTech, PL 100, 33014 TAMPEREEN YLIOPISTO, Tampere, Finland; Fimlab laboratories, Biokatu 4, 33520 Tampere, Finland. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbadis.2016.09.015DOI Listing
January 2017

Bone morphogenetic protein 4 regulates microRNA expression in breast cancer cell lines in diverse fashion.

Genes Chromosomes Cancer 2016 Mar 18;55(3):227-36. Epub 2015 Dec 18.

Institute of Biosciences and Medical Technology (BioMediTech), University of Tampere, Tampere, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/gcc.22324DOI Listing
March 2016

Exome sequencing identifies FANCM as a susceptibility gene for triple-negative breast cancer.

Proc Natl Acad Sci U S A 2014 Oct 6;111(42):15172-7. Epub 2014 Oct 6.

Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Central Hospital, Biomedicum Helsinki, FIN-00029 HUS, Helsinki, Finland;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1073/pnas.1407909111DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4210278PMC
October 2014

Breast-cancer risk in families with mutations in PALB2.

N Engl J Med 2014 Aug;371(6):497-506

From the Departments of Public Health and Primary Care (A.C.A., D.B., A.L., D.F.E.) and Oncology (D.F.E.), Centre for Cancer Genetic Epidemiology, Department of Oncology (D.F.E.), and Department of Medical Genetics and National Institute for Health Research Cambridge Biomedical Research Centre (M.T.), University of Cambridge, and the Department of Clinical Genetics, East Anglian Regional Genetics Service, Addenbrooke's Hospital (J.R., D.S., M.T.), Cambridge, and the Oncogenetics Team, Institute of Cancer Research and Royal Marsden National Health Service Foundation Trust, London (C.T., S.S., N.R.) - all in the United Kingdom; the Division of Medical Genetics, Department of Medicine, University of Washington, Seattle (S.C., M.-C.K.); the Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Central Hospital (T.H., S.K., H.N.), and the Department of Clinical Genetics, Helsinki University Central Hospital (K.A.), Helsinki, the Laboratory of Cancer Genetics and Tumor Biology, Department of Clinical Chemistry and Biocenter Oulu, University of Oulu, and the Laboratory of Cancer Genetics and Tumor Biology, Northern Finland Laboratory Center NordLab, Oulu University Hospital (K.P., R.W.), and the Department of Clinical Genetics, University of Oulu and Oulu University Hospital (J.S.M.), Oulu, Biocenter Kuopio and Cancer Center of Eastern Finland, University of Eastern Finland, Kuopio (A.M.), and the Institute of Biomedical Technology-Cancer Genomics, University of Tampere, Tampere (A.K.) - all in Finland; the Center for Medical Genetics, Ghent University Hospital, Ghent, Belgium (K.D.L., B.P., K.B.M.C.); the Molecular Diagnostics Laboratory, Institute of Nuclear and Radiologic Sciences and Technology, Energy and Safety, National Center for Scientific Research Demokritos, Athens (F.F., D.Y.); the Department of Genetics, Eastern Ontario Regional Genetics Program, Children's Hospital of Eastern Ontario, Ottawa (E.T.), Samuel Lunenfeld Research

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1400382DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4157599PMC
August 2014

Evaluation of the RHINO gene for breast cancer predisposition in Finnish breast cancer families.

Breast Cancer Res Treat 2014 Apr 22;144(2):437-41. Epub 2014 Feb 22.

Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Central Hospital, Biomedicum Helsinki, P. O. Box 700, 00029, Helsinki, Finland,

View Article

Download full-text PDF

Source
http://link.springer.com/content/pdf/10.1007/s10549-014-2884
Web Search
http://link.springer.com/10.1007/s10549-014-2884-z
Publisher Site
http://dx.doi.org/10.1007/s10549-014-2884-zDOI Listing
April 2014

KPNA7, a nuclear transport receptor, promotes malignant properties of pancreatic cancer cells in vitro.

Exp Cell Res 2014 Mar 23;322(1):159-67. Epub 2013 Nov 23.

Institute of Biomedical Technology, FIN-33014 University of Tampere and BioMediTech, Biokatu 6, 33520 Tampere, Finland; Fimlab Laboratories, Biokatu 4, 33520 Tampere, Finland. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.yexcr.2013.11.014DOI Listing
March 2014

The expression patterns of gremlin 1 and noggin in normal adult and tumor tissues.

Int J Clin Exp Pathol 2013 15;6(7):1400-8. Epub 2013 Jun 15.

Institute of Biomedical Technology, University of Tampere and BioMediTech, Tampere, Finland.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3693206PMC
February 2014

The diverse role of miR-31 in regulating cancer associated phenotypes.

Genes Chromosomes Cancer 2013 Dec 2;52(12):1103-13. Epub 2013 Sep 2.

Institute of Biomedical Technology, University of Tampere and BioMediTech, Tampere, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/gcc.22107DOI Listing
December 2013

HOXB13 G84E mutation in Finland: population-based analysis of prostate, breast, and colorectal cancer risk.

Cancer Epidemiol Biomarkers Prev 2013 Mar 4;22(3):452-60. Epub 2013 Jan 4.

Johanna Schleutker, Medical Biochemistry and Genetics, Institute of Biomedicine, Kiinamyllynkatu 10, FI-20014 University of Turku, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1055-9965.EPI-12-1000-TDOI Listing
March 2013

Bone morphogenetic protein 4 expression in multiple normal and tumor tissues reveals its importance beyond development.

Mod Pathol 2013 Jan 17;26(1):10-21. Epub 2012 Aug 17.

Institute of Biomedical Technology, University of Tampere and BioMediTech, Tampere, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/modpathol.2012.128DOI Listing
January 2013

Silencing of the ARP2/3 complex disturbs pancreatic cancer cell migration.

Anticancer Res 2013 Jan;33(1):45-52

Institute of Biomedical Technology, FIN_33014 University of Tampere, Finland.

View Article

Download full-text PDF

Source
http://ar.iiarjournals.org/content/33/1/45.full.pdf
Web Search
January 2013

Rare copy number variants observed in hereditary breast cancer cases disrupt genes in estrogen signaling and TP53 tumor suppression network.

PLoS Genet 2012 21;8(6):e1002734. Epub 2012 Jun 21.

Laboratory of Cancer Genetics, Department of Clinical Genetics and Biocenter Oulu, Oulu University Hospital, University of Oulu, Oulu, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1371/journal.pgen.1002734DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3380845PMC
September 2012

Both inhibition and enhanced expression of miR-31 lead to reduced migration and invasion of pancreatic cancer cells.

Genes Chromosomes Cancer 2012 Jun 16;51(6):557-68. Epub 2012 Feb 16.

Institute of Biomedical Technology, University of Tampere and Centre for Laboratory Medicine, Tampere University Hospital, Tampere, Finland.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/gcc.21941
Publisher Site
http://dx.doi.org/10.1002/gcc.21941DOI Listing
June 2012

Bone morphogenetic protein 4-a fascinating regulator of cancer cell behavior.

Authors:
Anne Kallioniemi

Cancer Genet 2012 Jun;205(6):267-77

Institute of Biomedical Technology/BioMediTech, University of Tampere and Fimlab Laboratories, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cancergen.2012.05.009DOI Listing
June 2012

Breast cancer-associated Abraxas mutation disrupts nuclear localization and DNA damage response functions.

Sci Transl Med 2012 Feb;4(122):122ra23

Laboratory of Cancer Genetics, Department of Clinical Genetics, Institute of Clinical Medicine and Biocenter Oulu, University of Oulu, Oulu University Hospital, Aapistie 5A, FI-90220 Oulu, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1126/scitranslmed.3003223DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3869525PMC
February 2012

MED29, a component of the mediator complex, possesses both oncogenic and tumor suppressive characteristics in pancreatic cancer.

Int J Cancer 2011 Dec 25;129(11):2553-65. Epub 2011 Mar 25.

Institute of Medical Technology, University of Tampere and Centre for Laboratory Medicine, Tampere University Hospital, Tampere, Finland.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/ijc.25924
Publisher Site
http://dx.doi.org/10.1002/ijc.25924DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3118263PMC
December 2011

Analysis of BMP4 and BMP7 signaling in breast cancer cells unveils time-dependent transcription patterns and highlights a common synexpression group of genes.

BMC Med Genomics 2011 Nov 25;4:80. Epub 2011 Nov 25.

Laboratory of Cancer Genetics, Institute of Biomedical Technology, University of Tampere and Centre for Laboratory Medicine, Tampere University Hospital, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1755-8794-4-80DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3229454PMC
November 2011

Bone morphogenetic protein -4 and -5 in pancreatic cancer--novel bidirectional players.

Exp Cell Res 2011 Sep 17;317(15):2136-46. Epub 2011 Jun 17.

Laboratory of Cancer Genetics, Institute of Medical Technology, University of Tampere and Tampere University Hospital, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.yexcr.2011.06.001DOI Listing
September 2011

RAD51C is a susceptibility gene for ovarian cancer.

Hum Mol Genet 2011 Aug 25;20(16):3278-88. Epub 2011 May 25.

Department of Obstetrics and Gynecology, Helsinki University Central Hospital, Helsinki, 00029 HUS, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/hmg/ddr229DOI Listing
August 2011

DNA copy number analysis on tissue microarrays.

Authors:
Anne Kallioniemi

Methods Mol Biol 2010 ;664:127-34

Institute of Medical Technology, University of Tampere and Tampere University Hospital, Tampere, Finland.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/978-1-60761-806-5_13
Publisher Site
http://dx.doi.org/10.1007/978-1-60761-806-5_13DOI Listing
December 2010

Parallel inhibition of cell growth and induction of cell migration and invasion in breast cancer cells by bone morphogenetic protein 4.

Breast Cancer Res Treat 2010 Nov 25;124(2):377-86. Epub 2010 Feb 25.

Laboratory of Cancer Genetics, Institute of Medical Technology, University of Tampere and Tampere University Hospital, 33014, Tampere, Finland.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s10549-010-0808-0
Publisher Site
http://dx.doi.org/10.1007/s10549-010-0808-0DOI Listing
November 2010

19q13 amplification is associated with high grade and stage in pancreatic cancer.

Genes Chromosomes Cancer 2010 Jun;49(6):569-75

Laboratory of Cancer Genetics, Institute of Medical Technology, University of Tampere, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/gcc.20767DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2855495PMC
June 2010

Bone morphogenetic proteins in breast cancer: dual role in tumourigenesis?

Endocr Relat Cancer 2010 Jun 21;17(2):R123-39. Epub 2010 Apr 21.

Institute of Medical Technology, University of Tampere and Tampere University Hospital, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1677/ERC-09-0273DOI Listing
June 2010

Characterization of the 7q21-q22 amplicon identifies ARPC1A, a subunit of the Arp2/3 complex, as a regulator of cell migration and invasion in pancreatic cancer.

Genes Chromosomes Cancer 2009 Apr;48(4):330-9

Laboratory of Cancer Genetics, Institute of Medical Technology, University of Tampere and Tampere University Hospital, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/gcc.20643DOI Listing
April 2009

BMP7 influences proliferation, migration, and invasion of breast cancer cells.

Cancer Lett 2009 Mar 5;275(1):35-43. Epub 2008 Nov 5.

Laboratory of Cancer Genetics, Institute of Medical Technology, University of Tampere and Tampere University Hospital, FIN-33014 Tampere, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.canlet.2008.09.028DOI Listing
March 2009

Deciphering downstream gene targets of PI3K/mTOR/p70S6K pathway in breast cancer.

BMC Genomics 2008 Jul 24;9:348. Epub 2008 Jul 24.

Institute of Biomedicine and Biomedicum Biochip Center, Genome-Scale Biology Research Program, University of Helsinki, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2164-9-348DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2496917PMC
July 2008

PPM1D silencing by RNA interference inhibits proliferation and induces apoptosis in breast cancer cell lines with wild-type p53.

Cancer Genet Cytogenet 2008 Apr;182(1):33-9

Institute of Medical Technology, University of Tampere, FIN-33014 University of Tampere, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cancergencyto.2007.12.013DOI Listing
April 2008

Hypermethylated MAL gene - a silent marker of early colon tumorigenesis.

J Transl Med 2008 Mar 17;6:13. Epub 2008 Mar 17.

Department of Cancer Prevention, Institute for Cancer Research, The Norwegian Radium Hospital, Rikshospitalet University Hospital, Oslo, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1479-5876-6-13DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2292685PMC
March 2008

CGH microarrays and cancer.

Authors:
Anne Kallioniemi

Curr Opin Biotechnol 2008 Feb 26;19(1):36-40. Epub 2007 Dec 26.

Laboratory of Cancer Genetics, Tampere University Hospital and Institute of Medical Technology, University of Tampere, Biokatu 6, Tampere FI-33014, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.copbio.2007.11.004DOI Listing
February 2008

Identification of differentially expressed genes after PPM1D silencing in breast cancer.

Cancer Lett 2008 Jan 30;259(1):61-70. Epub 2007 Oct 30.

Laboratory of Cancer Genetics, Tampere University Hospital, FI-33014 University of Tampere, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.canlet.2007.09.019DOI Listing
January 2008

A comprehensive expression survey of bone morphogenetic proteins in breast cancer highlights the importance of BMP4 and BMP7.

Breast Cancer Res Treat 2007 Jun 21;103(2):239-46. Epub 2006 Sep 21.

Laboratory of Cancer Genetics, Institute of Medical Technology, University of Tampere and Tampere University Hospital, Biokatu 6, Tampere, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-006-9362-1DOI Listing
June 2007

Large genomic BRCA2 rearrangements and male breast cancer.

Cancer Detect Prev 2006 20;30(6):530-4. Epub 2006 Nov 20.

Laboratory of Cancer Genetics, Tampere University Hospital and Institute of Medical Technology, University of Tampere, Teiskontie 35, FIN-33520 Tampere, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cdp.2006.10.002DOI Listing
March 2007

Intersex-like (IXL) is a cell survival regulator in pancreatic cancer with 19q13 amplification.

Cancer Res 2007 Mar;67(5):1943-9

Laboratory of Cancer Genetics, Institute of Medical Technology, University of Tampere and Tampere University Hospital, Tampere, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-06-3387DOI Listing
March 2007

Pancreatic adenocarcinoma -- genetic portrait from chromosomes to microarrays.

Genes Chromosomes Cancer 2006 Aug;45(8):721-30

Laboratory of Cancer Genetics, Institute of Medical Technology, University of Tampere and Tampere University Hospital, Tampere, Finland.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/gcc.20337
Publisher Site
http://dx.doi.org/10.1002/gcc.20337DOI Listing
August 2006

Bone morphogenetic protein 7 is widely overexpressed in primary breast cancer.

Genes Chromosomes Cancer 2006 Apr;45(4):411-9

Laboratory of Cancer Genetics, Institute of Medical Technology, University of Tampere and Tampere University Hospital, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/gcc.20307DOI Listing
April 2006

The serine-threonine protein phosphatase PPM1D is frequently activated through amplification in aggressive primary breast tumours.

Breast Cancer Res Treat 2006 Feb 28;95(3):257-63. Epub 2005 Oct 28.

Laboratory of Cancer Genetics, Institute of Medical Technology, University of Tampere and Tampere University Hospital, Tampere, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-005-9017-7DOI Listing
February 2006

Search for large genomic alterations of the BRCA1 gene in a Finnish population.

Cancer Genet Cytogenet 2005 Nov;163(1):57-61

Laboratory of Cancer Genetics and Institute of Medical Technology, University of Tampere, Teiskontie 35, Tampere FIN-33521, Finland. .

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cancergencyto.2005.05.014DOI Listing
November 2005

High-resolution genomic and expression profiling reveals 105 putative amplification target genes in pancreatic cancer.

Neoplasia 2004 Sep-Oct;6(5):432-9

Laboratory of Cancer Genetics, University of Tampere and Tampere University Hospital, Tampere, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1593/neo.04130DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1550328PMC
April 2005

CDK4 is a probable target gene in a novel amplicon at 12q13.3-q14.1 in lung cancer.

Genes Chromosomes Cancer 2005 Feb;42(2):193-9

Department of Occupational Medicine, Finnish Institute of Occupational Health, Helsinki, Finland.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/gcc.20122
Publisher Site
http://dx.doi.org/10.1002/gcc.20122DOI Listing
February 2005

Frequent amplification and overexpression of CCND1 in male breast cancer.

Int J Cancer 2004 Oct;111(6):968-71

Laboratory of Cancer Genetics, Institute of Medical Technology, University of Tampere and Tampere University Hospital, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.20307DOI Listing
October 2004

Effects of Herceptin treatment on global gene expression patterns in HER2-amplified and nonamplified breast cancer cell lines.

Oncogene 2004 Jan;23(4):1010-3

Laboratory of Cancer Genetics, Institute of Medical Technology, University of Tampere and Tampere University Hospital, FIN-33520 Tampere, Finland.

View Article

Download full-text PDF

Source
http://research.med.helsinki.fi/sysbio/csb/pubs/herceptin_on
Web Search
http://www.nature.com/doifinder/10.1038/sj.onc.1207200
Publisher Site
http://dx.doi.org/10.1038/sj.onc.1207200DOI Listing
January 2004

Amplification of a 280-kilobase core region at the ERBB2 locus leads to activation of two hypothetical proteins in breast cancer.

Am J Pathol 2003 Nov;163(5):1979-84

Laboratory of Cancer Genetics, Institute of Medical Technology, University of Tampere and Tampere University Hospital, Tampere, FIN-33014 Finland.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1892409PMC
http://dx.doi.org/10.1016/S0002-9440(10)63556-0DOI Listing
November 2003

CGH-Plotter: MATLAB toolbox for CGH-data analysis.

Bioinformatics 2003 Sep;19(13):1714-5

Institute of Signal Processing, Tampere University of Technology, 33101 Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/bioinformatics/btg230DOI Listing
September 2003

[Gene expression profile as a crystal ball].

Authors:
Anne Kallioniemi

Duodecim 2003 ;119(12):1101-2

View Article

Download full-text PDF

Source
August 2003

Cloning of BCAS3 (17q23) and BCAS4 (20q13) genes that undergo amplification, overexpression, and fusion in breast cancer.

Genes Chromosomes Cancer 2002 Dec;35(4):311-7

Laboratory of Cancer Genetics, Institute of Medical Technology, University of Tampere and Tampere University Hospital, Tampere, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/gcc.10121DOI Listing
December 2002

Frequent amplification of 8q24, 11q, 17q, and 20q-specific genes in pancreatic cancer.

Genes Chromosomes Cancer 2002 Dec;35(4):353-8

Laboratory of Cancer Genetics, Tampere University Hospital and University of Tampere, Tampere, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/gcc.10122DOI Listing
December 2002

Molecular signatures of breast cancer--predicting the future.

Authors:
Anne Kallioniemi

N Engl J Med 2002 Dec;347(25):2067-8

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMe020152DOI Listing
December 2002

Impact of DNA amplification on gene expression patterns in breast cancer.

Cancer Res 2002 Nov;62(21):6240-5

Howard Hughes Medical Institute-NIH Research Scholar, Bethesda, Maryland 20892, USA.

View Article

Download full-text PDF

Source
November 2002

Targets of gene amplification and overexpression at 17q in gastric cancer.

Cancer Res 2002 May;62(9):2625-9

Department of Medical Genetics, University of Helsinki and Helsinki University Central Hospital, Helsinki 00290, Finland.

View Article

Download full-text PDF

Source
May 2002

New insights into testicular germ cell tumorigenesis from gene expression profiling.

Cancer Res 2002 Apr;62(8):2359-64

Department of Genetics, Institute for Cancer Research, The Norwegian Radium Hospital, N-0310 Oslo, Norway.

View Article

Download full-text PDF

Source
April 2002

Clinical and functional target validation using tissue and cell microarrays.

Curr Opin Chem Biol 2002 Feb;6(1):97-101

Cancer Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD 20892-8000, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s1367-5931(01)00283-6DOI Listing
February 2002